STAT Plus: Vertex CEO complains to U.K. prime minister about stalled talks over a pricey drug

“We are questioning this ecosystem, as it is unable to value life-changing medicines for the patients that need them.”

More From BioPortfolio on "STAT Plus: Vertex CEO complains to U.K. prime minister about stalled talks over a pricey drug"